$0.70
-0.01 (-0.77%)
Open$0.74
Previous Close$0.71
Day High$0.75
Day Low$0.69
52W High$1.80
52W Low$0.48
Volume—
Avg Volume213.5K
Market Cap22.61M
P/E Ratio—
EPS$-1.17
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+3,831.0% upside
Current
$0.70
$0.70
Target
$27.69
$27.69
$21.92
$27.69 avg
$40.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.15M | 2.17M | 3.54M |
| Net Income | -40,815,073 | -36,966,454 | -86,327 |
| Profit Margin | -1,893.6% | -1,798.9% | -2.4% |
| EBITDA | -39,658,588 | -37,914,520 | -134,724 |
| Free Cash Flow | — | — | -61,141 |
| Rev Growth | -0.6% | -0.6% | +8.8% |
| Debt/Equity | — | — | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.53 | -1.09% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $361.16 | +0.17% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.13 | -0.16% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $494.74 | -0.98% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $628.06 | -0.59% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $297.43 | +1.33% | 69.3 | 39.97B |